Last update 01 Nov 2024

The First Affiliated Hospital,Zhejiang University School of Medicine

Hospital

Overview

Tags

Neoplasms
Hemic and Lymphatic Diseases
Immune System Diseases
Bispecific antibody
CAR-T
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms4
Hemic and Lymphatic Diseases2
Infectious Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
CAR-T2
Bispecific antibody2
Monoclonal antibody2
Antibody drug conjugate (ADC)1
Universal CAR-T1
Top 5 TargetCount
HER2 x HLA-G1
BCMA x CD191
c-Met(Hepatocyte growth factor receptor)1
ROS1(Proto-oncogene tyrosine-protein kinase ROS)1
CLDN18.2(Claudin 18.2)1

Related

8
Drugs associated with The First Affiliated Hospital,Zhejiang University School of Medicine
anti-CD19/BCMA CAR-T therapy (Zhejiang University)
Target
BCMA x CD19
Mechanism
BCMA inhibitors [+1]
Active Org.
The First Affiliated Hospital,Zhejiang University School of Medicine
Originator Org.
The First Affiliated Hospital,Zhejiang University School of Medicine
Active Indication
Autoimmune Diseases
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
allogeneic CAR-T (Zhejiang Universtiy)
Target
CD19
Mechanism
CD19 inhibitors
Active Org.
The First Affiliated Hospital,Zhejiang University School of Medicine
Originator Org.
The First Affiliated Hospital,Zhejiang University School of Medicine
Active Indication
Hematologic Diseases
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
CD19/CD22 CAR-T (Zhejiang Universtiy)
Target
CD19 x CD22
Mechanism
CD19 inhibitors [+1]
Active Org.
The First Affiliated Hospital,Zhejiang University School of Medicine
Originator Org.
The First Affiliated Hospital,Zhejiang University School of Medicine
Active Indication
Hematologic Neoplasms
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
24
Clinical Trials associated with The First Affiliated Hospital,Zhejiang University School of Medicine
ChiCTR2400090896
/ SuspendedNot ApplicableIIT
A multicenter, open-label, prospective, parallel-controlled study on the improvement of nutritional status in peritoneal dialysis patients using amino acid peritoneal dialysis solution.
ChiCTR2400090819
/ SuspendedEarly Phase 1IIT
The impact of midday fasting on the weight and health of overweight and obese adults
ChiCTR2400090635
/ SuspendedPhase 1/2IIT
An Open-Label, Phase 1/2a, Single-Arm Study Assessing the Safety, Pharmacokinetics and Efficacy of CMDE005 in Patients with EGFR-Positive Advanced Solid Tumors
100 Clinical Results associated with The First Affiliated Hospital,Zhejiang University School of Medicine
Login to view more data
0 Patents (Medical) associated with The First Affiliated Hospital,Zhejiang University School of Medicine
Login to view more data
100 Deals associated with The First Affiliated Hospital,Zhejiang University School of Medicine
Login to view more data
100 Translational Medicine associated with The First Affiliated Hospital,Zhejiang University School of Medicine
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
3
2
Preclinical
Phase 1 Clinical
3
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free